Nationwide Fund Advisors’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Nationwide Fund Advisors’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,652	Closed	-$225K	–	3266
2016 Q3	$225K	Buy	5,652 +241	+4%	+$2.69K	﹤0.01%	2575
2016 Q2	$68K	Buy	5,411 +4,143	+327%	+$38.6K	﹤0.01%	3034
2016 Q1	$10K	Hold	1,268	–	–	﹤0.01%	3160
2015 Q4	$13K	Hold	1,268	–	–	﹤0.01%	3122
2015 Q3	$12K	Hold	1,268	–	–	﹤0.01%	3172
2015 Q2	$22K	Sell	1,268 -1	-0.1%	-$15	﹤0.01%	3162
2015 Q1	$14K	Hold	1,269	–	–	﹤0.01%	3206
2014 Q4	$10K	Hold	1,269	–	–	﹤0.01%	3158
2014 Q3	$13K	Hold	1,269	–	–	﹤0.01%	3209
2014 Q2	$78K	Buy	+1,269	New	+$77.2K	﹤0.01%	3062

Nationwide Fund Advisors's TBRA Position: Q4 2016 in Review

Nationwide Fund Advisors sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 5,652 shares — an estimated $225K sold.

Nationwide Fund Advisors first reported a position in TBRA in Q2 2014 and held it in 10 quarters. The position peaked at $225K in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

Nationwide Fund Advisors reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 5,652 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $225K.
Nationwide Fund Advisors first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
Nationwide Fund Advisors's Tobira Therapeutics, Inc. Common Stock position peaked at $225K in Q3 2016.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Nationwide Fund Advisors's 13F filing for Q4 2016, filed 27 Jan 2017.